• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

CANCER

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit. Explore the live graph.

p53 and Autophagy Drugs

August 24, 2018Autophagy, Cancer, Vizit Graphs
p53 and Autophagy Drugs

Explore p53 Pathways and Autophagy related drugs with Vizit. Explore the live graph.

Cancer and Male Infertility miRNAs

August 24, 2018Cancer, Male Infertility, miRNA, Other, Vizit Graphs
Cancer and Male Infertility miRNAs

Review the miRNAs and related genes common to Cancer and Male infertility. Explore the live graph.

Vizit Graphs Tag Cloud

SOD1 BREAST CANCER PSEUDOMONAS AERUGINOSA IFNG INSULIN NEURODEGENERATIVE DISORDERS IL6 ESCHERICHIA COLI LISTERIA MONOCYTOGENES PARKINSON DISEASE PORPHYROMONAS GINGIVALIS ERBB-2 DIABETES MELLITUS FOXP3 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE STREPTOCOCCUS PNEUMONIAE CELL DEATH CD4 TNF IL23A INFLAMMATION TH17 CELLS HELICOBACTER PYLORI DOXORUBICIN AUTOPHAGY CTLA4 REMICADE AGING CASP3 METFORMIN RHEUMATOID ARTHRITIS CELL DIFFERENTIATION CANDIDA ALBICANS TP53 CLOSTRIDIUM DIFFICILE ALZHEIMER'S DISEASE CELL DIVISION CANCER RECEPTOR STAPHYLOCOCCUS AUREUS ANGIOGENESIS APOPTOTIC PROCESS CELL PROLIFERATION IMMUNE RESPONSE IL17A

© 2019 Biovista Vizit All Rights Reserved.